Implementation of a Rapid Recovery Protocol in Total Knee Arthroplasty
NCT ID: NCT03823573
Last Updated: 2023-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
175 participants
INTERVENTIONAL
2019-01-10
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rehabilitation After Fast-track Total Knee Arthroplasty
NCT01329081
Total Knee Arthroplasty: Fast Track Protocol is the Future?
NCT03869996
Fast-track Rehabilitation After Total Knee or Hip Arthroplasty
NCT03035435
Blood Flow Restriction Training Following Total Knee Arthroplasty
NCT02763488
Adductor Under Sartorial Canal Catheter (KTT) Versus Femoral Catheter (KTF) in a Quick Rehabilitation Process After Total Knee Replacement
NCT02873637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rapid recovery protocol
They will start walking the day of surgery. Levobupivacain 5mg/ml will be placed in the knee tissues. Tranexamic acid inside the knee. No drains.
Walk within 24 hours
Patients will start walking on different timings. Patients on the rapid recovery protocol won't be using drains.
Classic protocol
They will start walking 3 days after surgery. Levobupivacain 5 mg/ml will be placed in the femoral nerve. Tranexamic acid inside the knee. A Redon drain will be used.
Walk within 24 hours
Patients will start walking on different timings. Patients on the rapid recovery protocol won't be using drains.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Walk within 24 hours
Patients will start walking on different timings. Patients on the rapid recovery protocol won't be using drains.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 55-79
* Consent
Exclusion Criteria
* Epilepsy
* Pulmonary embolism
55 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ignacio Aguado Maestro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ignacio Aguado Maestro
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario del Río Hortega
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P1102-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.